Zoetis | ZTS - Cash And Equivalent

Stock Price
116.80
Daily Change
-1.46 -1.23%
Monthly
-4.54%
Yearly
-19.12%
Q2 Forecast
114.39

Zoetis reported $2.08B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
AbbVie USD 5.23B 400M Dec/2025
Align Technology USD 1B 103.43M Sep/2025
Bayer EUR 5.9B 1.34B Sep/2025
Bristol-Myers Squibb USD 10.21B 5.52B Dec/2025
Charles River Laboratories USD 213.77M 6.67M Dec/2025
Coherus Biosciences USD 88.88M 14.47M Dec/2025
Dentsply International USD 326M 37M Dec/2025
Eli Lilly USD 7.27B 2.52B Dec/2025
Henry Schein USD 136M 9M Sep/2025
Idexx Laboratories USD 180.07M 28.1M Dec/2025
Illumina USD 1.42B 368M Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
J&J USD 19.71B 1.48B Dec/2025
Laboratory Of America USD 532.3M 65.8M Dec/2025
Merck USD 18.17B 10.16B Sep/2025
Neogen USD 145.34M 6.46M Sep/2025
Pacira USD 158.54M 10.96M Dec/2025
Perrigo USD 432.1M 22.1M Sep/2025
Pfizer USD 1.34B 295M Sep/2025
Phibro Animal Health USD 55.49M 17.28M Dec/2025
Quest Diagnostics USD 420M 12M Dec/2025
Sanofi EUR 7.66B 1.25B Dec/2025
Sanofi EUR 7.66B 1.25B Dec/2025
Zoetis USD 2.08B 649M Sep/2025